We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.

AusPAR: Dexamethasone (intravitreal implant)

Australian Public Assessment Report

AusPAR

AusPAR: Dexamethasone (intravitreal implant) [PDF, 2.61 MB]

AusPAR: Dexamethasone (intravitreal implant) [DOCX, 6.86 MB]

Attachment: Product Information: Dexamethasone (intravitreal implant) [PDF, 390.51 KB]

Attachment: Product Information: Dexamethasone (intravitreal implant) [DOCX, 281.53 KB]

Attachment: Extract from Clinical Evaluation: dexamethasone (intravitreal implant) [PDF, 2.82 MB]

Attachment: Extract from Clinical Evaluation: dexamethasone (intravitreal implant) [DOCX, 8.37 MB]

Device/Product Name

Ozurdex

Active ingredients

Dexamethasone (intravitreal implant)

AusPAR Date

19 February 2019

Published

6 May 2019

Submission Number

PM-2017-00871-1-4

Submission Type

Extension of indications

Decision

Approved

Product types

Prescription medicines